Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
03/06/2008 | CA2658736A1 Method for the production of insulin-like growth factor-i |
03/05/2008 | EP1895009A1 Polyunsaturated fatty acids in plants |
03/05/2008 | EP1895008A2 Isoprenoid biosynthesis |
03/05/2008 | EP1895005A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
03/05/2008 | EP1895003A1 Cells expressing recombinase |
03/05/2008 | EP1895002A1 Novel trypsin family serine proteases |
03/05/2008 | EP1895001A1 Novel trypsin family serine proteases |
03/05/2008 | EP1895000A1 Identification of a JAK2 mutation involved in polycythaemia vera |
03/05/2008 | EP1894999A1 Process for enzymatic reduction of alkyne derivatives |
03/05/2008 | EP1894933A2 Compositions, methods and kits pertaining to luminescent compounds |
03/05/2008 | EP1894467A2 Use of glyphosate resistant maize lines |
03/05/2008 | EP1893993A2 Crystal of a cytochrome-ligand complex and methods of use |
03/05/2008 | EP1893759A2 Methods for increasing the resistance of plants to hypoxic conditions |
03/05/2008 | EP1893755A1 Lipase production method |
03/05/2008 | EP1893754A2 Novel glutamic acid decarboxylase (gad) chimera and methods of use |
03/05/2008 | EP1893753A2 Novel sesquiterpene synthases and methods of their use |
03/05/2008 | EP1893638A2 Insect-specific protease recognition sequences |
03/05/2008 | EP1893631A2 Dimeric and multimeric fviia compounds |
03/05/2008 | EP1893231A2 Use of plasmin for preventing of reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions |
03/05/2008 | EP1893043A2 Reduced risk tobacco products and methods of making same |
03/05/2008 | EP1766050A4 Assay system using labeled oligonucleotides |
03/05/2008 | EP1572973A4 Mracs as modifiers of the rac pathway and methods of use |
03/05/2008 | EP1572861A4 Ap1 amine oxidase variants |
03/05/2008 | EP1514939B1 Chondroitin synthetase and nucleic acid coding for the enzyme |
03/05/2008 | EP1397487B1 Vitamin b6-phosphate phosphatase |
03/05/2008 | EP1292289B1 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
03/05/2008 | EP1214418B1 Nucleic acid which is obtained from tetrahymena and which codes for a delta-6-desaturase, the production thereof and use |
03/05/2008 | EP1100310B1 Plants, seeds and oils having an elevated total monounsaturated fatty acid content |
03/05/2008 | EP1064360B1 Luciferases, gfp fluorescent proteins, their nucleic acids and the use thereof in diagnostics |
03/05/2008 | EP0960337B1 Cathepsin K and breast cancer |
03/05/2008 | EP0876494B1 Production and secretion of actinomycete xylanases in a filamentous trichoderma fungus |
03/05/2008 | CN101137750A Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
03/05/2008 | CN101137749A Novel microbial enzymes and their use |
03/05/2008 | CN101137392A Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity |
03/05/2008 | CN101134953A Recombinant human pancreas kininogenase |
03/05/2008 | CN101134952A Human urine kininogenase and method for making same |
03/05/2008 | CN101134951A Plasminogen and cultivation method therefor |
03/05/2008 | CN101134950A Method for co-production of cellulose and other enzymes by using transgenic plants |
03/05/2008 | CN101134949A Beta-glucanase, encoding gene thereof, recombinant plasmid and bacterial strain and uses thereof |
03/05/2008 | CN101134948A S-adenosine methilanin synthase mutant, DNA encoding the mutant and application of the mutant |
03/05/2008 | CN101134941A Method for preparing EGCG hydrolytic enzyme and producing EGC and gallic acid by aspergillus oryzae |
03/05/2008 | CN101134106A Pharmaceutical composition containing human urine kininogenase for treating cerebral infarction |
03/05/2008 | CN100372995C Process for bio-bleaching of kraft pulp using bacterial consortia |
03/05/2008 | CN100372944C The use of PDE4D in the screening for medicaments against atherosclerosis |
03/05/2008 | CN100372939C Farnesyl pyrophosphate synthase protein, nucleic acid and promoter region thereof |
03/05/2008 | CN100372938C Gene encoding labyrinthin, a marker for cancer |
03/05/2008 | CN100372936C I (vibrio cholerae) vaccine candidates and method of their constructing |
03/05/2008 | CN100372930C Low-Lipoxygenase 1 barley |
03/05/2008 | CN100372927C Tdcbc/pcka gene-inactivated microorganism and method of producing l-threonine using the same |
03/05/2008 | CN100372925C Method for producing cyclodextrin glucose based transferase and dedicated strain |
03/05/2008 | CA2600168A1 Markers of renal transplant rejection and renal damage |
03/04/2008 | US7339092 Plant activation of Cry8Bb1 by insertion of a plant protease-sensitive site |
03/04/2008 | US7339091 Recombinant Bacillus phytases and uses thereof |
03/04/2008 | US7339048 Genes encoding genetic stability, gene expression and folding proteins |
03/04/2008 | US7339047 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases |
03/04/2008 | US7339038 Heparanase specific molecular probes and their use in research and medical applications |
03/04/2008 | US7339028 Mahoganoid polypeptides, and related compositions and methods |
03/04/2008 | US7339027 Human prolactin antagonist-angiogenesis inhibitor fusion proteins |
03/04/2008 | US7338932 Methods of modulating functions of polypeptide GalNAc-transferases and of screening test substances to find agents herefor, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments |
03/04/2008 | US7338931 Administering a hyaluronic acid and an insulin for treating diabetes; structure compacted due to the passing of the structure over its point of collapse with buried polar groups and a minimum size; the hyaluronic acid surrounds the insulin |
03/04/2008 | US7338801 Double transposition methods for manipulating nucleic acids |
03/04/2008 | US7338793 Methods and compositions for cyclizing diterpenes |
03/04/2008 | US7338792 Process for the preparation of D-pantothenic acid and/or salts thereof |
03/04/2008 | US7338780 Method for producing tripeptides and/or peptides longer than tripeptides |
03/04/2008 | US7338776 Production of UGPPase |
03/04/2008 | US7338774 Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same |
03/04/2008 | US7338770 Using calcitonin precursor protein as diagnostic tool in detection of cancer and sepsis |
03/04/2008 | US7338769 Methods for identifying agonists of cypin |
03/04/2008 | US7338761 Detection and quantification of human herpes viruses |
02/28/2008 | WO2008024372A2 Pullulanase variants with increased productivity |
02/28/2008 | WO2008023455A1 Tyrosinase inhibitor |
02/28/2008 | WO2008023060A1 Fermentation process |
02/28/2008 | WO2008023052A1 Combination of a fvii and a thrombin-activable factor x |
02/28/2008 | WO2008022963A2 Isolation and characterization of a novel pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains |
02/28/2008 | WO2008022570A1 Method to alleviate abiotic stress in plants |
02/28/2008 | WO2008022468A1 Compositions and methods for treating myelosuppression |
02/28/2008 | WO2008008181A3 Method of production of para-hydroxycinnamic acid using a thermostable tal enzyme |
02/28/2008 | WO2008008179A3 Immobilized tal biocatalyst for production of para-hydroxycinnamic acid |
02/28/2008 | WO2007148121A3 Nucleic acid molecules encoding an enzyme that degrades long-chain n-alkanes |
02/28/2008 | WO2007145539A3 Crystal structure of a substrate complex of miox |
02/28/2008 | WO2007132461A3 Classification of protein sequences and uses of classified proteins |
02/28/2008 | WO2007131657A3 Novel alkaline protease from bacillus gibsonii and washing and cleaning agents containing said novel alkaline protease |
02/28/2008 | WO2007128441A3 A novel group of esterases for the production of fine and speciality chemicals |
02/28/2008 | WO2007120522A3 Permuted and nonpermuted luciferase biosensors |
02/28/2008 | WO2007112757A3 A process for concentration of a polypeptide |
02/28/2008 | WO2007103989A8 Aldolases, nucleic acids encoding them and methods for making and using them |
02/28/2008 | WO2007099459A3 Fad-2 mutants and high oleic plants |
02/28/2008 | WO2007093848A3 Crystalline enoyl-(acyl-carrier-protein) reductase from heliobacter pylori |
02/28/2008 | WO2007091159A3 Compositions and methods for treating lysosomal storage diseases |
02/28/2008 | WO2007079938B1 Detergents or cleaning agents comprising a special amylase |
02/28/2008 | WO2006138466A3 Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules |
02/28/2008 | WO2006116682A3 Polypeptides having endoglucanase activity and polynucleotides encoding same |
02/28/2008 | US20080052794 Casein Kinase Stress-Related Polypeptides And Methods Of Use In Plants |
02/28/2008 | US20080052792 Transgenic plant cell comprising expression vector coding regulatory protein for use in enhancement of drought resistant plants |
02/28/2008 | US20080051560 Regulation of Gene Expression By Protein Methylation |
02/28/2008 | US20080051559 MT-SP1 polypeptides |
02/28/2008 | US20080051556 Novel PTP-20, PCP-2, BDP1, CLK, and SIRP proteins and related products and methods |
02/28/2008 | US20080051420 New Compounds 317 |
02/28/2008 | US20080051404 Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
02/28/2008 | US20080051358 using CLN2 protein having pepstatin-insensitive carboxyl protease activity to treat LINCL; mutation or absence of CLN2 is causative of classical late infantile neuronal ceroid lipofuscinosis (LINCL) |